New N(4)-substituted piperazine naphthamide derivatives as BACE-1 inhibitors.
Synthesis and enzymatic evaluation of new series of N(4)-substituted piperazine naphthamide derivatives as BACE-1 inhibitors for the treatment of Alzheimer's disease are reported.